144 related articles for article (PubMed ID: 8619866)
1. Increased circulating hepatocyte growth factor in the early stage of acute myocardial infarction.
Matsumori A; Furukawa Y; Hashimoto T; Ono K; Shioi T; Okada M; Iwasaki A; Nishio R; Sasayama S
Biochem Biophys Res Commun; 1996 Apr; 221(2):391-5. PubMed ID: 8619866
[TBL] [Abstract][Full Text] [Related]
2. Serum levels of endostatin, vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF) in patients with acute myocardial infarction undergoing early reperfusion therapy.
Seko Y; Fukuda S; Nagai R
Clin Sci (Lond); 2004 May; 106(5):439-42. PubMed ID: 14965340
[TBL] [Abstract][Full Text] [Related]
3. Hepatocyte growth factor plasma levels after myocardial infarction are not affected by recombinant tissue-type plasminogen-activator therapy.
Molnar C; Buratti T; Wiedermann CJ; Tilg H
Eur Cytokine Netw; 2000 Mar; 11(1):87-90. PubMed ID: 10705304
[TBL] [Abstract][Full Text] [Related]
4. [Changes of serum hepatocyte growth factor in coronary artery disease].
Suzuki H; Murakami M; Kondo T; Shibata M; Ezumi H; Okabayashi H; Yorozuya M; Makishima N; Hamazaki Y; Nakatani M; Namiki A; Katagiri T
J Cardiol; 2000 May; 35(5):319-24. PubMed ID: 10834175
[TBL] [Abstract][Full Text] [Related]
5. [Significance of hepatocyte growth factor measurement in patients with acute myocardial infarction].
Sato T; Yoshinouchi T; Sugimoto T; Sakamoto T; Fujieda H; Sato H; Murao S; Kobayashi H; Ohe T
J Cardiol; 1998 Aug; 32(2):77-82. PubMed ID: 9752615
[TBL] [Abstract][Full Text] [Related]
6. A pilot study of cardiac troponin I in patients with acute myocardial infarction and unstable angina.
Selim NA; Hmouda HT
Saudi Med J; 2002 May; 23(5):526-8. PubMed ID: 12070573
[TBL] [Abstract][Full Text] [Related]
7. Hepatocyte growth factor and vascular endothelial growth factor in ischaemic heart disease.
Suzuki H; Murakami M; Shoji M; Iso Y; Kondo T; Shibata M; Ezumi H; Hamazaki Y; Koba S; Katagiri T
Coron Artery Dis; 2003 Jun; 14(4):301-7. PubMed ID: 12826929
[TBL] [Abstract][Full Text] [Related]
8. Immediate increase in circulating hepatocyte growth factor/scatter factor by heparin.
Matsumori A; Ono K; Okada M; Miyamoto T; Sato Y; Sasayama S
J Mol Cell Cardiol; 1998 Oct; 30(10):2145-9. PubMed ID: 9799666
[TBL] [Abstract][Full Text] [Related]
9. Level of ventricular myosin light chains 1 and 2 determined by ELISA in serum of patients with acute myocardial infarction.
Costache L; Popescu P; Filip Z; Ilieşiu D; Lazăr C; Nanea T
Roum Arch Microbiol Immunol; 1995; 54(1-2):31-42. PubMed ID: 8993112
[TBL] [Abstract][Full Text] [Related]
10. A superior early myocardial infarction marker. Human heart-type fatty acid-binding protein.
Chan CP; Sanderson JE; Glatz JF; Cheng WS; Hempel A; Renneberg R
Z Kardiol; 2004 May; 93(5):388-97. PubMed ID: 15160274
[TBL] [Abstract][Full Text] [Related]
11. Very early diagnosis and risk stratification of patients admitted with suspected acute myocardial infarction by the combined evaluation of a single serum value of cardiac troponin-T, myoglobin, and creatine kinase MB(mass).
Jurlander B; Clemmensen P; Wagner GS; Grande P
Eur Heart J; 2000 Mar; 21(5):382-9. PubMed ID: 10666352
[TBL] [Abstract][Full Text] [Related]
12. Production of hepatocyte growth factor during acute myocardial infarction.
Zhu Y; Hojo Y; Ikeda U; Shimada K
Heart; 2000 Apr; 83(4):450-5. PubMed ID: 10722550
[TBL] [Abstract][Full Text] [Related]
13. Predictors of myocardial damage prior to hospital admission among patients with acute chest pain or other symptoms raising a suspicion of acute coronary syndrome.
Svensson L; Isaksson L; Axelsson C; Nordlander R; Herlitz J
Coron Artery Dis; 2003 May; 14(3):225-31. PubMed ID: 12702926
[TBL] [Abstract][Full Text] [Related]
14. Radioimmunoassay of myoglobin in human serum. Results in patients with acute myocardial infarction.
Stone MJ; Willerson JT; Gomez-Sanchez CE; Waterman MR
J Clin Invest; 1975 Nov; 56(5):1334-9. PubMed ID: 1184754
[TBL] [Abstract][Full Text] [Related]
15. Serum hepatocyte growth factor levels predict long-term clinical outcome after percutaneous coronary revascularization.
Susen S; Sautière K; Mouquet F; Cuilleret F; Chmaït A; McFadden EP; Hennache B; Richard F; de Groote P; Lablanche JM; Dallongeville J; Bauters C; Jude B; Van Belle E
Eur Heart J; 2005 Nov; 26(22):2387-95. PubMed ID: 16105849
[TBL] [Abstract][Full Text] [Related]
16. [Relationship between early peaking of serum myosin light chain 1 level and washout phenomenon of creatine kinase in acute myocardial infarction].
Okumachi F; Yoshikawa J; Koizumi K; Shiratori K; Yoshida K; Akasaka T; Maeda K; Takagi T; Minagoe S; Kato H
J Cardiol; 1994; 24(2):81-9. PubMed ID: 8164150
[TBL] [Abstract][Full Text] [Related]
17. Plasma levels of the monocyte chemotactic and activating factor/monocyte chemoattractant protein-1 are elevated in patients with acute myocardial infarction.
Matsumori A; Furukawa Y; Hashimoto T; Yoshida A; Ono K; Shioi T; Okada M; Iwasaki A; Nishio R; Matsushima K; Sasayama S
J Mol Cell Cardiol; 1997 Jan; 29(1):419-23. PubMed ID: 9040055
[TBL] [Abstract][Full Text] [Related]
18. [Troponin I in acute ischemic cardiopathy].
Lucia P; Coppola A; Manetti LL; Cerroni F; Sebastiani ML; Colliardo A; Strappini PM; De Martinis C
Ital Heart J Suppl; 2000 Feb; 1(2):232-40. PubMed ID: 10731381
[TBL] [Abstract][Full Text] [Related]
19. Circulating level of hepatocyte growth factor as a useful tumor marker in patients with early-stage gastric carcinoma.
Tanaka K; Miki C; Wakuda R; Kobayashi M; Tonouchi H; Kusunoki M
Scand J Gastroenterol; 2004 Aug; 39(8):754-60. PubMed ID: 15513361
[TBL] [Abstract][Full Text] [Related]
20. [Vascular endothelium-related factors and atherosclerosis/arteriosclerosis: serum hepatocyte growth factor as a possible indicator of vascular lesions].
Nishimura M; Ushiyama M; Nanbu A; Ohtsuka K; Yoshimura M
Rinsho Byori; 1998 Jul; 46(7):671-7. PubMed ID: 9721534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
